Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Niederreiter, L. Niederreiter, A. Schmiderer, H. Tilg, A. Djanani (2019)
Colorectal cancer screening and prevention—pros and consmemo - Magazine of European Medical Oncology, 12
I. Heidegger (2019)
PSA screening—a matter of debate?memo - Magazine of European Medical Oncology, 12
SM Miller (2008)
Primary prevention, aging, and cancer: overview and future perspectivesCancer, 113
Suzanne Miller, Deborah Bowen, J. Lyle, M. Clark, D. Mohr, J. Wardle, R. Ceballos, K. Emmons, E. Gritz, L. Marlow (2008)
Cancer and Aging : Challenges and Opportunities across the Cancer Control Continuum Supplement to Cancer Primary Prevention , Aging , and Cancer : Overview and Future Perspectives
Magdalena Seidl-Philipp, V. Nguyen (2019)
Cutaneous melanoma—The benefit of screening and preventive measuresmemo - Magazine of European Medical Oncology, 12
editorial memo (2019) 12:192–193 https://doi.org/10.1007/s12254-019-00526-7 Holger Rumpold Received: 20 August 2019 / Accepted: 22 August 2019 © Springer-Verlag GmbH Austria, part of Springer Nature 2019 Cancer is the second most common cause of death specific antigen measurements for early detection of in developed countries, preceded only by heart dis- prostate cancer are key examples illustrating the po- eases. Due to demographic changes, the number of tential harm for overtreating indolent or harmless dis- cancer patients is rising and will increase to an esti- eases. mated 15 million people in the United States by 2020, However, prevention is more than only performing for example. This increase is complemented by the specific examinations in obviously healthy people. It recent progress in treatment of cancer. This has led to is much better described as the “protection of health a significant increase of cancer-related survival rates by personal and community-wide efforts,” as defined across all entities. The success in the fight against by Miller and colleagues [1]. As well as describing the cancer is further augmented by screening programs burden of disease, this also includes identification of enabling the detection of cancer in early stages, when the causes of cancer. Due to the
memo - Magazine of European Medical Oncology – Springer Journals
Published: Sep 26, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.